Cambridge Investment Research Advisors’s First Trust SMID Capital Strength ETF FSCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61M Buy
98,049
+408
+0.4% +$14.7K 0.01% 1241
2026
Q1
$3.44M Buy
97,641
+615
+0.6% +$22.5K 0.01% 1198
2025
Q4
$3.47M Buy
97,026
+6,303
+7% +$226K 0.01% 1130
2025
Q3
$3.33M Buy
90,723
+73,620
+430% +$2.69M 0.01% 1146
2025
Q2
$611K Buy
17,103
+10,775
+170% +$374K ﹤0.01% 2361
2025
Q1
$219K Buy
6,328
+28
+0.4% +$994 ﹤0.01% 3130
2024
Q4
$223K Hold
6,300
﹤0.01% 3105
2024
Q3
$222K Hold
6,300
﹤0.01% 3067
2024
Q2
$202K Buy
+6,300
New +$202K ﹤0.01% 3029

Other funds holding FSCS

Cambridge Investment Research Advisors's FSCS Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its First Trust SMID Capital Strength ETF (FSCS) stake by 0.42% in Q2 2026, buying an estimated $14.7K and bringing the position to 98,049 shares worth $3.61M. The position accounts for 0.01% of the portfolio, ranked #1241.

Cambridge Investment Research Advisors first reported a position in FSCS in Q2 2024 and has held it in 9 quarters since. 9 funds tracked by Wall St. Rank hold FSCS as of Q2 2026.

  • Cambridge Investment Research Advisors held 98,049 shares of First Trust SMID Capital Strength ETF worth $3.61M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 408 First Trust SMID Capital Strength ETF shares in Q2 2026, an estimated $14.7K.
  • First Trust SMID Capital Strength ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1241 holding.
  • Cambridge Investment Research Advisors first reported a position in First Trust SMID Capital Strength ETF in Q2 2024 and has held it in 9 quarters since.
  • 9 funds tracked by Wall St. Rank held First Trust SMID Capital Strength ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.